Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)

CAPS Rating: 5 out of 5

A biopharmaceutical company that acquires and advances a diversified portfolio of drug candidates, with a focus on oncology, urology and other critical health challenges for which there are few other treatment options.

Recs

0
Player Avatar michaeltbryant (< 20) Submitted: 10/5/2009 1:17:21 AM : Outperform Start Price: $9.03 SPPI Score: +17.87

Great brand. Pharma - defensive

Featured Broker Partners


Advertisement